Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tabassum Moonira"'
Autor:
Brian E. Ford, Shruti S. Chachra, Katrina Rodgers, Tabassum Moonira, Ziad H. Al-Oanzi, Quentin M. Anstee, Helen L. Reeves, Jörn M. Schattenberg, Rebecca J. Fairclough, David M. Smith, Dina Tiniakos, Loranne Agius
Publikováno v:
Molecular Metabolism, Vol 72, Iss , Pp 101722- (2023)
Objectives: The Glucokinase Regulatory Protein GKRP, encoded by GCKR, enables acute regulation of liver glucokinase to support metabolic demand. The common human GCKR rs1260326:Pro446 > Leu variant within a large linkage disequilibrium region associa
Externí odkaz:
https://doaj.org/article/bfd2b304f9c64daea275414d8bcedee8
Autor:
Ahmed Alshawi, Loranne Agius, Marc Foretz, Benoit Viollet, Silvia Marin, Natasha S. Adam-Primus, Shruti S. Chachra, Ziad H. Al-Oanzi, Tabassum Moonira, Marta Cascante, Catherine Arden, Brian E. Ford
Publikováno v:
The Journal of Biological Chemistry
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2020, 295 (10), pp.3330-3346. ⟨10.1074/jbc.ra120.012533⟩
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2020, 295 (10), pp.3330-3346. ⟨10.1074/jbc.ra120.012533⟩
International audience; The chronic effects of metformin on liver gluconeogenesisinvolve repression of theG6pcgene, which is regulated by thecarbohydrate-response element–binding protein throughraised cellular intermediates of glucose metabolism. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f735b9110a996135298766fd5778907
https://pubmed.ncbi.nlm.nih.gov/31974165
https://pubmed.ncbi.nlm.nih.gov/31974165
Autor:
Ziad H. Al-Oanzi, Sophia Fountana, Ahmed Alshawi, Loranne Agius, John L. Petrie, Susan J. Tudhope, G.L. Patman, Catherine Arden, Tabassum Moonira, Helen L. Reeves
Publikováno v:
Diabetes, Obesity and Metabolism. 19:1078-1087
Aim Small molecule activators of glucokinase (GKAs) have been explored extensively as potential anti-hyperglycaemic drugs for type 2 diabetes (T2D). Several GKAs were remarkably effective in lowering blood glucose during early therapy but then lost t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a86c23beda7aa723b50186a21c319555
https://doi.org/10.1111/dom.12910
https://doi.org/10.1111/dom.12910
Publikováno v:
Diabetic Medicine. 33:32-34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cd531aa1cf5188cbbef3585606256b0
https://doi.org/10.1111/dme.14_13047
https://doi.org/10.1111/dme.14_13047
Autor:
Ziad H, Al-Oanzi, Sophia, Fountana, Tabassum, Moonira, Susan J, Tudhope, John L, Petrie, Ahmed, Alshawi, Gillian, Patman, Catherine, Arden, Helen L, Reeves, Loranne, Agius
Publikováno v:
Diabetes, obesitymetabolism. 19(8)
Small molecule activators of glucokinase (GKAs) have been explored extensively as potential anti-hyperglycaemic drugs for type 2 diabetes (T2D). Several GKAs were remarkably effective in lowering blood glucose during early therapy but then lost their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::103eb2ad4fe767f364a510f7c6c83da3
https://pubmed.ncbi.nlm.nih.gov/28206714
https://pubmed.ncbi.nlm.nih.gov/28206714